Norges Bank
ABCL icon

Norges Bank’s AbCellera Biologics ABCL Stock Holding History

Norges Bank’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-176,386
Closed -$603K – 9
2025
Q4 		$603K Buy
+176,386
New +$787K ﹤0.01% 1544
2025
Q3 		– Sell
-630,938
Closed -$2.16M – 9
2025
Q2 		$2.16M Hold
630,938
– – ﹤0.01% 1421
2025
Q1 		$1.41M Sell
630,938
-653,595
-51% -$1.87M ﹤0.01% 1578
2024
Q4 		$3.76M Buy
1,284,533
+362,319
+39% +$1.01M ﹤0.01% 1568
2024
Q3 		$2.4M Hold
922,214
– – ﹤0.01% 1640
2024
Q2 		$2.73M Hold
922,214
– – ﹤0.01% 1675
2024
Q1 		$4.18M Hold
922,214
– – ﹤0.01% 1651
2023
Q4 		$5.27M Hold
922,214
– – ﹤0.01% 1659
2023
Q3 		$4.24M Sell
922,214
-653,447
-41% -$3.98M ﹤0.01% 1713
2023
Q2 		$10.2M Hold
1,575,661
– – ﹤0.01% 1523
2023
Q1 		$11.9M Buy
1,575,661
+928,962
+144% +$8.44M ﹤0.01% 1504
2022
Q4 		$6.55M Buy
646,699
+124,289
+24% +$1.44M ﹤0.01% 1703
2022
Q3 		$5.17M Buy
522,410
+237,041
+83% +$2.6M ﹤0.01% 1753
2022
Q2 		$3.04M Hold
285,369
– – ﹤0.01% 1845
2022
Q1 		$2.78M Hold
285,369
– – ﹤0.01% 1947
2021
Q4 		$4.08M Buy
285,369
+165,175
+137% +$2.51M ﹤0.01% 1938
2021
Q3 		$2.41M Buy
120,194
+70,194
+140% +$1.24M ﹤0.01% 2025
2021
Q2 		$1.1M Buy
+50,000
New +$1.38M ﹤0.01% 2101

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank's ABCL Position: Q1 2026 in Review

Norges Bank sold out of AbCellera Biologics (ABCL) in Q1 2026, closing a stake of 176,386 shares — an estimated $603K sold.

Norges Bank first reported a position in ABCL in Q2 2021 and held it in 18 quarters. The position peaked at $11.9M in Q1 2023. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Norges Bank reported no remaining AbCellera Biologics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 176,386 AbCellera Biologics shares in Q1 2026, an estimated $603K.
  • Norges Bank first reported a position in AbCellera Biologics in Q2 2021 and held it in 18 quarters.
  • Norges Bank's AbCellera Biologics position peaked at $11.9M in Q1 2023.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.